Barclays’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.1K | Buy |
+8,074
| New | +$12.3K | ﹤0.01% | 4681 |
|
|
2025
Q4 | – | Sell |
-7,883
| Closed | -$12.8K | – | 5239 |
|
|
2025
Q3 | $12.8K | Sell |
7,883
-7,917
| -50% | -$15.5K | ﹤0.01% | 4999 |
|
|
2025
Q2 | $36K | Buy |
15,800
+732
| +5% | +$1.21K | ﹤0.01% | 4755 |
|
|
2025
Q1 | $23.4K | Buy |
15,068
+3,209
| +27% | +$6.51K | ﹤0.01% | 4770 |
|
|
2024
Q4 | $27.9K | Buy |
11,859
+10,866
| +1,094% | +$36.7K | ﹤0.01% | 4873 |
|
|
2024
Q3 | $3.6K | Buy |
+993
| New | +$3.96K | ﹤0.01% | 5050 |
|
|
2022
Q2 | – | Sell |
-15,074
| Closed | -$63K | – | 5015 |
|
|
2022
Q1 | $63K | Buy |
+15,074
| New | +$63.4K | ﹤0.01% | 4010 |
|
|
2021
Q4 | – | Sell |
-4
| Closed | – | – | 4125 |
|
|
2021
Q3 | $0 | Sell |
4
-51
| -93% | -$322 | ﹤0.01% | 4738 |
|
|
2021
Q2 | $0 | Sell |
55
-35
| -39% | -$217 | ﹤0.01% | 4866 |
|
|
2021
Q1 | $1K | Sell |
90
-58
| -39% | -$429 | ﹤0.01% | 4579 |
|
|
2020
Q4 | $1K | Buy |
148
+100
| +208% | +$1.07K | ﹤0.01% | 4821 |
|
|
2020
Q3 | $1K | Hold |
48
| – | – | ﹤0.01% | 5138 |
|
|
2020
Q2 | $1K | Buy |
+48
| New | +$532 | ﹤0.01% | 5465 |
|
|
2020
Q1 | – | Sell |
-18
| Closed | – | – | 6129 |
|
|
2019
Q4 | $0 | Sell |
18
-3,177
| -99% | -$41.6K | ﹤0.01% | 6334 |
|
|
2019
Q3 | $40K | Buy |
3,195
+3,150
| +7,000% | +$41.6K | ﹤0.01% | 5995 |
|
|
2019
Q2 | $1K | Sell |
45
-1,455
| -97% | -$32.5K | ﹤0.01% | 6821 |
|
|
2019
Q1 | $47K | Sell |
1,500
-1,961
| -57% | -$55.8K | ﹤0.01% | 5919 |
|
|
2018
Q4 | $113K | Buy |
+3,461
| New | +$114K | ﹤0.01% | 4959 |
|
|
2018
Q3 | – | Sell |
-6,052
| Closed | -$162K | – | 7102 |
|
|
2018
Q2 | $162K | Buy |
+6,052
| New | +$160K | ﹤0.01% | 4889 |
|
Other funds holding AUTL
MCO
SP
AC
TAM
FLSM
LCM
